CMET-14. CLINICAL PRESENTATION, TREATMENT, AND OUTCOME IN PATIENTS WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT OF EXTRANODAL NATURAL KILLER/T-CELL LYMPHOMA

di Nevel, Kathryn, Daras, Mariza
Pubblicato in Neuro Oncol (2017)

Clinical presentation, treatment, and outcomes of patients with central nervous system involvement in extranodal natural killer/T-cell lymphoma

di Nevel, Kathryn S, Pentsova, Elena, Daras, Mariza
Pubblicato in Leuk Lymphoma (2019)

CMET-40. THE DEVELOPMENT OF BRAIN METASTASIS IN THE PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) AND MELANOMA TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A RETROSPECT...

di Chaul-Barbosa, Caroline, Niotis, Kellyann, Hellmann, Matthew, Callahan, Margaret, Daras, Mariza
Pubblicato in Neuro Oncol (2017)

NIMG-40. USE OF DYNAMIC CONTRAST ENHANCED MRI IN PREDICTING RESPONSE TO IMMUNOTHERAPY IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA

di Nevel, Kathryn, Schreyer, Mark, Panageas, Katherine, Young, Robert J, Daras, Mariza
Pubblicato in Neuro Oncol (2017)

12. OUTCOMES AFTER SURGICAL RESECTION OF MELANOMA BRAIN METASTASES IN THE AGE OF CHECKPOINT INHIBITOR TREATMENT

di Morshed, Ramin, Chung, Jason, Sudhakar, Vivek, Cummins, Daniel, Young, Jacob, Daras, Mariza, Aghi, Manish
Pubblicato in Neurooncol Adv (2020)

Novel Checkpoint Response to Genotoxic Stress Mediated by Nucleolin-Replication Protein A Complex Formation

di Kim, Kyung, Dimitrova, Diana D., Carta, Kristine M., Saxena, Anjana, Daras, Mariza, Borowiec, James A.
Pubblicazione 2005

HCP-15 BEVACIZUMAB IN HIGH GRADE GLIOMA PATIENTS FOLLOWING INTRACRANIAL HEMORRHAGE (ICH) - A REVIEW OF FIVE CASES

di Lin, Xuling, Daras, Mariza, Nolan, Craig, Gavrilovic, Igor, Mellinghoff, Ingo, DeAngelis, Lisa, Kaley, Thomas
Pubblicato in Neuro Oncol (2015)

Bevacizumab in high-grade glioma patients following intraparenchymal hemorrhage

di Lin, Xuling, Daras, Mariza, Pentsova, Elena, Nolan, Craig P., Gavrilovic, Igor T., DeAngelis, Lisa M., Kaley, Thomas J.
Pubblicato in Neurooncol Pract (2017)

Dynamic contrast‐enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases

di Hatzoglou, Vaios, Tisnado, Jamie, Mehta, Alpesh, Peck, Kyung K., Daras, Mariza, Omuro, Antonio M., Beal, Kathryn, Holodny, Andrei I.
Pubblicato in Cancer Med (2017)

CTIM-15. PRELIMINARY RESULTS OF A PHASE II STUDY OF NIVOLUMAB WITH HYPOFRACTIONATED RE-RADIATION AND BEVACIZUMAB FOR RECURRENT MGMT METHYLATED GLIOBLASTOMA

di Grommes, Christian, Mehta, Minesh, Miller, Alexandra, Daras, Mariza, Piotrowski, Anna, Boire, Adrienne, Butler, Brittany, Stone, Jacqueline, Pentsova, Elena, Kotecha, Rupesh, Morrison, Tara, Odia, Yazmin, Mellinghoff, Ingo, Beal, Kathryn
Pubblicato in Neuro Oncol (2020)

Twice Weekly Pulse and Daily Continuous Dose Erlotinib as Initial Treatment for Patients with EGFR-Mutant Lung Cancers and Brain Metastases

di Arbour, Kathryn C., Kris, Mark G., Riely, Gregory J., Ni, Ai, Beal, Kathryn, Daras, Mariza, Hayes, Sara A., Young, Robert J., Rodriguez, Christopher R, Ahn, Linda, Pao, William, Yu, Helena A.
Pubblicato in Cancer (2017)

Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers

di Li, Bob T., Lou, Emil, Hsu, Meier, Yu, Helena A., Naidoo, Jarushka, Zauderer, Marjorie G., Sima, Camelia, Johnson, Melissa L., Daras, Mariza, DeAngelis, Lisa M., Fleisher, Martin, Kris, Mark G., Azzoli, Christopher G.
Pubblicato in PLoS One (2016)

CTNI-47. PHASE II STUDY OF ABEMACICLIB IN RECURRENT GBM PATIENTS WITH CDKN2A/B LOSS AND INTACT RB

di Lee, Eudocia, Muzikansky, Alona, Arrillaga-Romany, Isabel, Chukwueke, Ugonma, Cloughesy, Timothy, Colman, Howard, Daras, Mariza, de Groot, John, Mcfaline-Figueroa, Jose, Nayak, Lakshmi, Prins, Robert, Reardon, David, Taylor, Jennie, Ligon, Keith, Wen, Patrick
Pubblicato in Neuro Oncol (2020)

ATIM-24. INTERIM RESULTS OF A PHASE II MULTICENTER STUDY OF THE CONDITIONALLY REPLICATIVE ONCOLYTIC ADENOVIRUS DNX-2401 WITH PEMBROLIZUMAB (KEYTRUDA) FOR RECURRENT GLIOBLASTOMA; CA...

di Zadeh, Gelareh, Lang, Frederick, Daras, Mariza, Cloughesy, Timothy, Colman, Howard, Ong, Shirley, Ramakrishna, Rohan, Vogelbaum, Michael, Groves, Morris, Nassiri, Farshad, Frederick, L Sue, Gammon, Karen, Fulling, Sheila, Rowland, Kari Anne, Mitchell, Erin, Ewald, Brett, Tufaro, Frank, Peterkin, Joanna
Pubblicato in Neuro Oncol (2018)

PATH-49. GENOMIC ATTRIBUTES OF TUMOR EVOLUTION AND TREATMENT RESPONSE IN DIFFUSE GLIOMA

di Lin, Andrew, Jonsson, Philip, Ogilvie, Shahiba, Chavan, Shweta, Nolan, Craig, Gavrilovic, Igor, Kaley, Thomas, Grommes, Christian, Pentsova, Elena, Diamond, Eli, Daras, Mariza, Stone, Jacqueline, DeAngelis, Lisa, Tabar, Viviane, Brennan, Cameron, Young, Robert, Rosenblum, Marc, Taylor, Barry, Mellinghoff, Ingo
Pubblicato in Neuro Oncol (2018)

ATIM-33. INTERIM RESULTS OF A PHASE II MULTI-CENTER STUDY OF ONCOLYTIC ADENOVIRUS DNX-2401 WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192)

di Aiken, Robert, Chen, Clark, Cloughesy, Timothy, Colman, Howard, Daras, Mariza, Groves, Morris, Khagi, Simon, Kumthekar, Priya, Lang, Frederick, Nassiri, Farshad, Ong, Shirley, Ramakrishna, Rohan, Sonabend, Adam, Vogelbaum, Michael, Zadeh, Gelareh, Agensky, Laura, Bidwell, Carin, Watkins, Barry, Tufaro, Frank, Peterkin, Joanna
Pubblicato in Neuro Oncol (2019)

Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma

di Grommes, Christian, Tang, Sarah S., Wolfe, Julia, Kaley, Thomas J., Daras, Mariza, Pentsova, Elena I., Piotrowski, Anna F., Stone, Jacqueline, Lin, Andrew, Nolan, Craig P., Manne, Malbora, Codega, Paolo, Campos, Carl, Viale, Agnes, Thomas, Alissa A., Berger, Michael F., Hatzoglou, Vaios, Reiner, Anne S., Panageas, Katherine S., DeAngelis, Lisa M., Mellinghoff, Ingo K.
Pubblicato in Blood (2019)

Frequency and Outcomes of Brain Metastases in Patients With HER2-Mutant Lung Cancers

di Offin, Michael, Feldman, Daniel, Ni, Ai, Myers, Mackenzie L., Lai, W. Victoria, Pentsova, Elena, Boire, Adrienne, Daras, Mariza, Jordan, Emmet J., Solit, David B., Arcila, Maria E., Jones, David R., Isbell, James M., Beal, Kathryn, Young, Robert J., Rudin, Charles M., Riely, Gregory J., Drilon, Alexander, Tabar, Viviane, DeAngelis, Lisa M., Yu, Helena A., Kris, Mark G., Li, Bob T.
Pubblicato in Cancer (2019)

LTBK-04. PHASE 2 MULTICENTER STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 (TASADENOTUREV) IN COMBINATION WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192)

di Zadeh, Gelareh, Daras, Mariza, Cloughesy, Timothy F, Colman, Howard, Kumthekar, Priya U, Chen, Clark C, Aiken, Robert, Groves, Morris D, Ong, Shirley, Ramakrishna, Rohan, Vogelbaum, Michael A, Khagi, Simon, Kaley, Thomas, Melear, Jason M, Peereboom, David M, Rodriguez, Analiz, Yankelevich, Maxim, Nair, Suresh G, Puduvalli, Vinay K, Nassiri, Farshad, Sonabend, Adam M, Agensky, Laura, Ewald, Brett, Levisetti, Matteo, Lang, Frederick F
Pubblicato in Neuro Oncol (2020)

Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas

di Omuro, Antonio, Beal, Kathryn, McNeill, Katharine, Young, Robert J., Thomas, Alissa, Lin, Xuling, Terziev, Robert, Kaley, Thomas J., DeAngelis, Lisa M., Daras, Mariza, Gavrilovic, Igor T., Mellinghoff, Ingo, Diamond, Eli L., McKeown, Andrew, Manne, Malbora, Caterfino, Andrew, Patel, Krishna, Bavisotto, Linda, Gorman, Greg, Lamson, Michael, Gutin, Philip, Tabar, Viviane, Chakravarty, Debyani, Chan, Timothy A., Brennan, Cameron W., Garrett-Mayer, Elizabeth, Karmali, Rashida A., Pentsova, Elena
Pubblicato in J Clin Oncol (2018)